Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | BMP1 | P13497 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6925851 | 0.88 | ALDH1A1 (0.48) | GAAMAPTALDH1A1LMNAKMT2A | |
| SCHEMBL6926341 | 0.88 | KMT2A (0.48) | GAAMAPTRAB9AALDH1A1KMT2A | |
| SCHEMBL4911967 | 0.74 | ALDH1A1 (0.70) | GAAPOLBALDH1A1LMNACYP3A4 | |
| SCHEMBL1309087 | 0.73 | GAA (0.48) | GAAPOLBMAPTRAB9AALDH1A1 | |
| SCHEMBL1309030 | 0.73 | GAA (0.48) | GAAPOLBMAPTRAB9AALDH1A1 | |
| SCHEMBL12653835 | 0.73 | SAE1 (0.46) | MAPTRAB9AALDH1A1LMNAKMT2A | |
| SCHEMBL8139629 | 0.72 | ALDH1A1 (0.49) | GAAPOLBRAB9AALDH1A1LMNA | |
| SCHEMBL16103917 | 0.72 | MMP1 (0.45) | MAPTRAB9AALDH1A1KMT2ACYP3A4 | |
| SCHEMBL16103893 | 0.72 | HTT (0.45) | MAPTRAB9AALDH1A1KMT2ACYP3A4 | |
| SCHEMBL6808541 | 0.72 | ALDH1A1 (0.79) | POLBMAPTRAB9AALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004074238-A1 | PHENETHYLAMINO SULFAMIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 2004-09-02 | — | — | WO | disclosed |
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | GAA 152/4885POLB 3615/4885MAPT 3227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.